Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo

References

• LiLWangHOngZYPolymer-and lipid-based nanoparticle therapeutics for the treatment of liver diseasesNano Today201054296312
   Web of Science ®Google Scholar
• WangSXuHXuJSustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-LipidAAPS PharmSciTech201011287087720490957
   PubMed Web of Science ®Google Scholar
• SmithJSXuZByrnesAPA quantitative assay for measuring clearance of adenovirus vectors by Kupffer cellsJ Virol Methods20081471546017850893
   PubMed Web of Science ®Google Scholar
• StockertRJThe asialoglycoprotein receptor: relationships between structure, function, and expressionPhysiol Rev19957535916097624395
   PubMed Web of Science ®Google Scholar
• PoelstraKPrakashJBeljaarsLDrug targeting to the diseased liverJ Control Release2012161218819722370583
   PubMed Web of Science ®Google Scholar
• SpiessMThe asialoglycoprotein receptor: a model for endocytic transport receptorsBiochemistry1990294310009100182125488
   PubMed Web of Science ®Google Scholar
• GeffenISpiessMAsialoglycoprotein receptorInt Rev Cytol B1992137181219
   Google Scholar
• BaenzigerJMaynardYHuman hepatic lectin. Physiochemical properties and specificityJ Biol Chem198025510460746137372599
   PubMed Web of Science ®Google Scholar
• BaenzigerJFieteDGalactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytesCell1980222 Pt 26116207448875
   PubMed Web of Science ®Google Scholar
• LeeYCTownsendRRHardyMRBinding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural featuresJ Biol Chem198325811992026848494
   PubMed Web of Science ®Google Scholar
• SatoATakagiMShimamotoAKawakamiSHashidaMSmall interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in miceBiomaterials20072871434144217141864
   PubMed Web of Science ®Google Scholar
• MandalADasSBasuMChakrabartiRDasNHepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosisJ Pharmacol Exp Ther20073203994100117138861
   PubMed Web of Science ®Google Scholar
• ManagitCKawakamiSYamashitaFHashidaMEffect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomesJ Pharm Sci200594102266227516136555
   PubMed Web of Science ®Google Scholar
• MuraoANishikawaMManagitCTargeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid compositionPharm Res200219121808181412523658
   PubMed Web of Science ®Google Scholar
• MammenMChoiSKWhitesidesGMPolyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren. [Poly valent interactions in biological systems: implications for the design and use of multivalent ligands and inhibitors]Angewandte Chemie19991102029082953 German
   Google Scholar
• KawakamiSMunakataCFumotoSYamashitaFHashidaMTargeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomesJ Drug Target20008313714210938523
   PubMed Web of Science ®Google Scholar
• GrantCWMKarlikSFlorioEA liposomal MRI contrast agent: phosphatidylethanolamine-DTPAMagn Reson Med19891122362432779414
   PubMed Web of Science ®Google Scholar
• IshiwataHVertut-DoïAHiroseTMiyajimaKPhysical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl etherChem Pharm Bull. (Tokyo)1995436100510117641302
   PubMed Web of Science ®Google Scholar
• YeaglePLCholesterol and the cell membraneBiochimica et Biophysica Acta19858223–42672873904832
   PubMed Web of Science ®Google Scholar
• GleasonMMMedowMSTulenkoTNExcess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cellsCirc Res19916912162272054935
   PubMed Web of Science ®Google Scholar
• KirbyCClarkeJGregoriadisGEffect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitroBiochem J198018625915987378067
   PubMed Web of Science ®Google Scholar
• KhorevOStokmaierDSchwardtOCuttingBErnstBTrivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptorBiorg Med Chem200816952165231
   PubMed Web of Science ®Google Scholar
• FengLZhangLYanZGuBWangCLuWExperimental study on liposomal drug delivery system for lymphatic targetingActa Biophysica Sinica201026735749
   Google Scholar
• ZhuSLiYYuBSynthesis of betavulgaroside III, a representative triterpene seco-glycosideJ Org Chem200873134978498518529027
   PubMed Web of Science ®Google Scholar
• ZhaoHLiXLiuHLiYWuCSynthesis and characterization of ferrocenylmethylaminobenzoic acids and their glucosyl estersSynth React Inorg Met Org Chem2000303473483
   Web of Science ®Google Scholar
• ParkIYKimTHKimYKChoiYJNahJWChoCSGalactosylated chitosan/carbonate apatite nanohybridization for cell specificity and high transfection efficiency as a DNA carrierKey Eng Mater2007342437440
   Google Scholar
• ParkI-KJiangH-LCookS-EGalactosylated chitosan (GC)-graft-poly (vinyl pyrrolidone)(PVP) as hepatocyte-targeting DNA carrier: in vitro transfectionArch Pharm Res200427121284128915648108
   PubMed Web of Science ®Google Scholar
• ZhangX-QWangX-LZhangP-CGalactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytesJ Control Release2005102374915681095
   PubMed Web of Science ®Google Scholar
• JereDJiangHAroteRDegradable polyethylenimines as DNA and small interfering RNA carriersExpert Opin Drug Deliv20096882783419558333
   PubMed Web of Science ®Google Scholar
• ParkIKimTKimSVisualization of transfection of hepatocytes by galactosylated chitosan-graft-poly (ethylene glycol)/DNA complexes by confocal laser scanning microscopyInt J Pharm2003257110311012711166
   PubMed Web of Science ®Google Scholar
• JiangH-LKwonJ-TKimE-MGalactosylated poly (ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targetingJ Control Release2008131215015718706946
   PubMed Web of Science ®Google Scholar
• DíezSMiguélizIDe IlarduyaCTTargeted cationic poly (D, L-lactic-co-glycolic acid) nanoparticles for gene delivery to cultured cellsCell Mol Biol Lett200914234736219194666
   PubMed Web of Science ®Google Scholar
• LongmuirKJHaynesSMBarattaJLKasabwallaNRobertsonRTLiposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfateInt J Pharm2009382122223319664697
   PubMed Web of Science ®Google Scholar
• BarattaJLNgoALopezBKasabwallaNLongmuirKJRobertsonRTCellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysisHistochem Cell Biol2009131671372619255771
   PubMed Web of Science ®Google Scholar
• LianTHoRJYTrends and developments in liposome drug delivery systemsJ Pharm Sci200190666768011357170
   PubMed Web of Science ®Google Scholar
• GabbayEGrierDFingerleRInteraction specificity of the anthracyclines with deoxyribonucleic acidBiochemistry197615102062776212
   PubMed Web of Science ®Google Scholar
• ColeyHAmosWTwentymanPWorkmanPExamination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell linesBr J Cancer199367613168099807
   PubMed Web of Science ®Google Scholar
• MarquardtDCenterMSDrug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cellsCancer Res19925211315731631591727
   PubMed Web of Science ®Google Scholar
• DüzgüneşNNirSMechanisms and kinetics of liposome–cell interactionsAdv Drug Del Rev1999401318
   Web of Science ®Google Scholar
• LiuXChuaCCGaoJPifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in miceScience Signaling20042863H933
   Google Scholar
• GabizonAASelective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesCancer Res19925248918961737351
   PubMed Web of Science ®Google Scholar
• GabizonAIsacsonRLibsonEClinical studies of liposome-encapsulated doxorubicinActa Oncol19943377797867993646
   PubMed Web of Science ®Google Scholar
• GabizonAMeshorerABarenholzYComparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administrationJ Natl Cancer Inst19867724594693461207
   PubMedGoogle Scholar
• ParkJWLiposome-based drug delivery in breast cancer treatmentBreast Cancer Res2002439512052251
   PubMed Web of Science ®Google Scholar
• GabizonAALiposomal anthracyclinesHematol Oncol Clin North Am1994824318040147
   PubMed Web of Science ®Google Scholar
• OlsonFMayhewEMaslowDRustumYSzokaFCharacterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomesEur J Cancer Clin Oncol19821821671767201392
   PubMedGoogle Scholar
• ChenZGSmall-molecule delivery by nanoparticles for anticancer therapyTrends Mol Med2010161259460220846905
   PubMed Web of Science ®Google Scholar
• WangRBillonePSMullettWMNanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trialsJ Nanomater201310.1155/2013/629681.
   Web of Science ®Google Scholar
• ChandaroyPSenAAlexandridisPHuiSWUtilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome–cell adhesionBiochimica et Biophysica Acta200215591324211825586
   PubMed Web of Science ®Google Scholar
• XiangYLiangLWangXWangJZhangXZhangQChloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomesJ Control Release2011152340241021435361
   PubMed Web of Science ®Google Scholar